Reaction

Testicular Germ Cell Cancer Metastatic reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 27 reports · 2 co-occurring drugs

As of the last recalculation, Testicular Germ Cell Cancer Metastatic appears in 27 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is FOSAPREPITANT DIMEGLUMINE (PRR 1,404.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Fosaprepitant Dimeglumine131,404.61,405.9
Aprepitant131,046.01,046.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.